Texaphyrins are porphyrin-like synthetic macrocycles that form highly stable complexes with large metal cations (1). One such drug is motexafin gadolinium (MGd, Xcytrin ® ), a chemotherapeutic agent, undergoing clinical trials including phase ΙΙΙ for the treatment of brain metastasis of lung cancer (2, 3) . MGd ( Fig.1 ), similar to porphyrins (4), selectively targets tumor cells by an unknown mechanism. Drug localization in tumors has been confirmed in animal models and in human clinical trials using magnetic resonance imaging (MRI), which detects the paramagnetic gadolinium ion (5) . MGd is easily reduced (half-wave potential-50 mV vs. normal hydrogen electrode), and in vitro may catalyze slow oxidation of intracellular reducing metabolites such as ascorbate, GSH and NADPH, generating superoxide and reactive oxygen species (ROS) in a process called futile redox cycling (6) . The drug is known to enhance treatment of tumor cells by radiation and cytotoxic drugs (7) (8) (9) . Generation of ROS in myeloma cells and induction of apoptosis has been demonstrated (10) . Recently, MGd has been shown to disrupt zinc metabolism and induce oxidative stress in human cancer cell lines (11) . These studies showed increased levels of intracellular free zinc, increased metallothionein transcripts, inhibition of thioredoxin reductase and cell death following incubation of human lung carcinoma cells with MGd in the presence of exogenous zinc acetate (11) . These findings could possibly result from oxidation of vicinal thiols or generation of ROS but the in vivo mechanisms are still largely unknown. We hypothesized that MGd may target ribonucleotide reductase, thioredoxin (Trx) or thioredoxin reductase (TrxR) (12) (13) (14) . All these enzymes have redox-active Cys residues and are central to cell growth and survival. The thioredoxin system, comprising Trx, TrxR and NADPH acts as a general protein disulfide reductase, where reduced Trx (Trx-(SH) 2 ) is used to reduce protein disulfides to protein dithiols ( protein-(SH) 2 ) and Trx-S 2 is reduced by TrxR using electrons from NADPH (13, 14) . Reactions 1 and 2:
Trx-(SH) 2 + Protein-S 2 Trx-S 2 + Protein-(SH) 2 (1)
The Trx system participates in a large number of biological functions via its protein disulfide reductase activity, involving thioredoxin peroxidases (peroxiredoxins), methionine sulfoxide reductases , regulation of transcription factors, ribonucleotide reduction and DNA synthesis or selenium metabolism (14) (15) (16) (17) (18) . Mammalian TrxR enzymes in the cytosol/nucleus (TrxR1) or mitochondria (TrxR2) are selenoproteins with a selenocysteine (Sec) in the active site (-Gly-Cys-Sec-Gly) and have a broad substrate specificity (19, 20) . Increased levels of Trx have been reported in many different tumors with a correlation to malignancy and poor prognosis (21, 22) . Inhibition of apoptosis by the Trx system has been suggested to be involved in drug resistance of tumor cells (23) (24) (25) (26) . Ribonucleotide reductase (RNR), another target for antitumor therapy, and a key S-phase enzyme reducing all four ribonucleotides to deoxyribonucleotides with electrons from Trx-(SH) 2 , is essential for DNA synthesis (27, 28) . A compound which interferes with the activity of RNR leads to the inhibition of DNA synthesis and cell proliferation. In this paper, we show that MGd is a substrate for mammalian TrxR, generating reactive oxygen species. It also acts as an inhibitor of Trxdependent disulfide reduction by blocking reduction of Trx-S 2 . No reaction was found between Trx-(SH) 2 and MGd. RNR was also strongly inhibited by MGd. We believe these results are important to explain the mechanism of action of MGd on tumor cells. (29) , human Trx1 and the double mutant C61S/C72S were prepared as described (30) . Calf thymus, human placenta TrxR1 as well as rat recombinant TrxR1 (31) with 50 % specific activity due to a content of truncated enzyme were used. E. coli RNR (32) was a kind gift of Prof. Britt-Marie Sjöberg and mouse R1 and R2 proteins of RNR were expressed and purified and the R2 protein activated as described by Thelander and coworkers (33, 34 2 , by MGd -E.coli or human Trx (0.5 mM) was reduced with 5 mM DTT for 30 min under nitrogen, after which DTT was removed by running the sample through a Sephadex G-25 column, with nitrogen equilibrated TE buffer. After mixing 20 µM Trx-(SH) 2 and 20 µM MGd in potassium phosphate buffer, pH 7.5, or in 50 mM Tris-Cl, pH 7.5, with or without 1 mM EDTA, oxidation of reduced Trx was measured as the decrease of SH-groups over time, after stopping the reaction with 6 M guanidine hydrochloride in TE buffer containing 1 mM DTNB. We used a molar extinction coefficient at 412 nm of 13.600 M Protein disulfide reduction using insulin -This assay was performed to measure the activity of Trx or TrxR ( Reactions 1 and 2) as described (29) . A total volume of 120 µl, contained 100 mM Tris-Cl pH 7.5, 2 mM EDTA, 0.1 mM NADPH, 0.3 mM insulin, 1.8 µM Trx and 0-140 µM MGd. The reaction was initiated by adding 5 nM rat TrxR to all tubes. After 20 min, the reaction was terminated by adding 500 µl of 1 mM DTNB in 6 M guanidine hydrochloride in TE buffer (pH 8.0); thereafter the amount of generated insulin SHgroups was measured at A 412 nm and quantified by the molar extinction coefficient of 13600 M -1 cm -1 for 2-nitro-5-thiobenzoic acid (29) . All kinetic experiments were performed at 20 MGd with varying NADPH was tested using glucose-6-phosphate to regenerate NADPH (35) . This experiment was performed in 50 mM potassium phosphate, pH 7.6, 1.5 mM EDTA, 10 mM glucose-6-phosphate, 0.2 Units/ml of glucose-6-phosphate dehydrogenase, 0.2 mM insulin, 10 µM human Trx and varying concentrations of NADPH (0.25-50 µM). After initiating the reactions by adding 10 nM TrxR, the samples were incubated at 37˚C for 15 min and reactions terminated by the addition of 6 M guanidine hydrochloride-1 mM DTNB in TE buffer to the samples and the absorbance at A 412 nm was determined to measure insulin SH-groups. TrxR activity by DTNB reduction -In a final volume of 0.50 ml, 100 mM Tris-Cl, pH 7. (33, 34) . Reducing equivalents were provided through either 4 mM DTT or 3 µM human Trx and 0.1 µM calf liver TrxR and 1 mM NADPH. The reaction was initiated by adding mouse RNR (5.5 µg R1 and 2.1 µg R2) (33, 34) 
Experimental procedures

Materials -
Results
The ultraviolet and visible spectrum of MGdMGd has a strong green color and as seen from the spectrum (Fig. 1) there was a relatively strong absorbance at 340 and 412 nm, which are wavelengths for spectrophotometric assays of the oxidation of NADPH or sulfhydryl groups by DTNB, respectively (29) . Adding 1 mM DTT to a 20 µM MGd solution resulted in no change of the spectrum after 30 min. The dithiol DTT is known to be a slow reductant of MGd but regeneration of the parent molecule by oxygen-dependent redox cycling obviously is fast generating ROS (6) . In our studies, we measured redox reactions at 340 nm in the presence of MGd and the Trx system without any corrections due to spectral changes in MGd.
MGd as a substrate for thioredoxin reductaseMGd is supplied as a solution in mannitol and previous measurements of the redox properties of the molecule using an oxygen electrode have been made in 50 mM HEPES, pH 7.5, 100 mM NaCl (6) . Initial experiments using this buffer with NADPH and 0.2 µM rat TrxR showed oxidation of NADPH at 340 nm. Addition of 1 mM EDTA, a standard condition for assays of Trx and TrxR (29), did not inhibit the reaction as if MGd would be complexed but rather slightly stimulated the reaction rate. This may be due to complexation of heavy metal ions in buffer salts, which may inhibit TrxR. Buffer used in the present study therefore all contained EDTA. As seen in Fig. 2A 4A) indicating that MGd bound to rat TrxR, and a corresponding trough was present at the low molecular weight eluted fractions. In fact, E. coli TrxR (Fig. 4B) bound more MGd and a calculation showed that approximately up to 6 molecules of MGd were eluted per enzyme dimer.
In contrast, the rat TrxR1 enzyme gave a ratio of 1.4:1 indicating a smaller amount of MGd bound.
MGd inhibits the activity of the thioredoxin system -The Trx system is an NADPH-dependent general disulfide reductase (13, 14, 18) . TrxR catalyzes the NADPH-dependent reduction of Tr-S 2 to Trx-(SH) 2 (Reaction 2). Through a combination of Reactions 1 and 2, the Trx system will catalyze NADPH-dependent disulfide reduction, and insulin disulfides are generally used to follow the reaction (13, 14, 18) . To study if MGd inhibited protein disulfide reduction, the mammalian Trx system was evaluated (Fig. 5) . In this experiment a low rate limiting amount of TrxR (5 nM (29) . When varying MGd (0-16 µM) and NADPH with saturating DTNB (5 mM), an IC 50 of 6 µM was obtained for MGd (Fig. 6) . Thus, MGd is a relatively strong direct inhibitor of TrxR activity. MGd inhibits the activity of ribonucleotide reductase -RNR is composed of two non identical subunits, which combined give activity (12, 27) . Initial experiments using E. coli RNR (32) showed that MGd was a strong inhibitor (data not shown). We then produced mouse RNR by separately expressing the two subunits (33, 34) in E. coli and reconstituting the tyrosol free radical of the R2 enzyme subunit. RNR activity was measured by using conversion of [ 3 H] CDP into [ 3 H] dCDP. Using the Trx system as an electron donor, MGd was a strong inhibitor of mouse RNR activity, with an IC 50 of 2 µM (Fig. 8) . Alternatively, 4 mM DTT was used as reducing substrate. Again, RNR activity was inhibited with an IC 50 of 6 µM (Fig.  8) . These results indicate a strong direct inhibitory effect of MGd on RNR.
Discussion
MGd is a novel and promising chemotherapeutic drug acting by a redox cycling mechanism. The present results show that MGd acts as a substrate of the cytosolic selenocysteine-dependent mammalian TrxR (19, 20, (38) (39) (40) , generating ROS from NADPH in the presence of oxygen. We demonstrate that the reaction end product was hydrogen peroxide. As other flavoproteins, TrxR has a low inherent NADPH oxidase activity (kcat 0.14 × min -1 ), which is stimulated up to 34-fold (kcat 4.7 × min -1 ) following alkylation of the selenol thiol -Cys-Sec-in the active site by DNCB (36, 37) . In the presence of 8 µM MGd there was a similar turnover rate of mammalian TrxR. Obviously, this is responsible for generating oxidative stress in cells as observed (10, 11) . The induced activity is of the same magnitude as that of naturally occurring NADPH oxidases (Nox enzymes) involved in redox signaling or transformation of cells (41) . Tumor cells often have up to 10-fold higher expression of TrxR compared with normal cells (38, 39) , it can be hypothesized that transformed cells are more susceptible to the MGd induced oxidative stress response, leading to cell death predominantly in tumor cell populations (42) (43) (44) . Previous results had reported that MGd reacts with reducing metabolites by using oxygen electrode measurements (6) . A comparison of the calculated reaction rates is shown in Table1. Obviously, mammalian TrxR reactivity is orders of magnitude faster than that of NADPH, GSH or ascorbate. The reactivity with NADPH was usually negligible in our experiments. Surprisingly, MGd did not react with E. coli or human Trx under any assay conditions. The reactivity is so slow that it should not play any role physiologically. Another remarkable fact is that the E. coli TrxR which displays a high degree of substrate specificity (36) showed a high reactivity with MGd. Furthermore, MGd was a powerful inhibitor of the E. coli Trx system. This effect was also detectable when assessing the mammalian Trx system, however the inhibition was much more moderate than for the E. coli TrxR. The effect of MGd on rat TrxR1 was demonstrated using DTNB as a direct substrate. Results showed an IC 50 -value of 6 µM. TrxR is an enzyme directly reducing e.g. dehydroascorbate by NADPH and this reaction should be blocked. Ascorbate is known to potentiate the effect of MGd (6, 10, 11) . In summary, the reactivity with Trx system will induce oxidative stress in cells through a major production of ROS. Inhibition of TrxR as a disulfide reductase involved in Trx-dependent reactions like peroxiredoxin activity may also play a major role. The other major effect of MGd discovered in our studies is a direct inhibition of the activity of RNR, an essential enzyme required for DNA synthesis and repair (12, 27) . In the case of the mammalian RNR, inhibition was direct on the enzyme and required low amounts of MGd. It occurred both with Trx and TrxR as well as with the artificial electron donor DTT, as electron donors, clearly demonstrating a direct effect on RNR. Inhibition of RNR will stop DNA synthesis, DNA repair and cell growth. This may be an important component of the anti-tumor activity of MGd. The low IC 50 of 2 µM of MGd for RNR makes it a strong inhibitor of the enzyme (Fig. 8) . Further studies are required to assess if MGd binds to RNR, and to analyze which of the two RNR subunits is targeted by MGd. RNR activity could also be indirectly affected as a downstream consequence of inhibition of the Trx system. Two recent publications have appeared of interest for understanding MGd (10, 11) . One study shows that MGd disrupts zinc metabolism in human cancer cell lines and that metallothionein genes are among the most strongly induced, indicating that MGd can mobilize intracellular zinc. Disruption of zinc metabolism and increases of free zinc would also inhibit TrxR (11). Magda et al show by an assay for TrxR using cellular lipoate reduction which is inhibited in the presence of MGd coroborating our results. Free zinc has obvious effects on enzymes with redox active SH-groups like TrxR, Trx or RNR. Interestingly, it was reported that the R2-subunit RNR was also induced in the presence of MGd (45) . In summary, we have described the effect of MGd on the thioredoxin system and RNR. We have demonstrated that MGd and NADPH reacts in the presence of TrxR, producing ROS which will generate oxidative stress in cells as has been demonstrated (46) . This may lead to induction of apoptosis through oxidation of Trx, via ASK1 mediated cell death (47, 48) . Additional redox dependent pathways may be disrupted as a result of inhibition of the Trx system as a disulfide reductase. We also demonstrate a direct inhibitory effect of MGd on RNR. Our results suggest that MGd may act on tumor cells by disrupting the redox balance and inducing oxidative stress apart from inhibiting DNA synthesis due to lack of deoxyribonucleotides . 
